Will Type 2 Diabetics Take Insulin at Any Point in Their Care?
Yes, many patients with type 2 diabetes will eventually require insulin therapy due to the progressive nature of the disease, with insulin being an essential treatment option when other therapies fail to maintain glycemic control. 1, 2
The Progressive Nature of Type 2 Diabetes
Type 2 diabetes is characterized by progressive β-cell dysfunction over time 3. Due to this progressive nature, insulin therapy is eventually indicated for many patients with type 2 diabetes 1. The most recent 2022 AACE guidelines explicitly state that clinicians should discuss with patients "the likelihood that most persons with T2D ultimately require a combination of multiple complementary antihyperglycemic agents, in addition to lifestyle interventions, to attain and maintain optimal glycemic control" 2.
When Insulin Should Be Initiated
Immediate Insulin Initiation
Insulin should be started immediately in the following situations:
- A1C >10% (86 mmol/mol) with symptomatic hyperglycemia or catabolism (weight loss) 2
- Blood glucose ≥300 mg/dL (16.7 mmol/L) 2
- Newly diagnosed patients with markedly symptomatic and/or elevated blood glucose levels 1
In these scenarios, basal insulin along with noninsulin therapy is recommended from the outset 2.
Sequential Insulin Initiation
For patients not meeting the above criteria, insulin becomes necessary when:
- Combination therapy with other agents fails to achieve or maintain glycemic goals 2
- A1C >9.0% with symptomatic hyperglycemia 2
- After 3 months of maximum tolerated doses of noninsulin agents without achieving A1C targets 1, 4
Treatment Pathway
The typical progression follows this algorithm:
- Initial therapy: Metformin monotherapy (unless contraindicated) 1, 2
- After 3 months if A1C not at goal: Add second agent (GLP-1 RA, SGLT2i, DPP-4 inhibitor, or insulin) 1, 2
- After another 3 months if still not at goal: Progress to three-drug combination or insulin 1
- Eventually: Many patients will require basal insulin, then potentially basal-bolus regimens 1, 2
Important Clinical Considerations
Preferred Approach Before Insulin
The 2022 AACE guidelines recommend that most persons with T2D who require intensification should initially be prescribed a GLP-1 RA before insulin 2. Insulin is then added if further intensification is required. This approach offers equal or better glucose lowering with lower hypoglycemia risk and weight reduction versus weight gain 2.
Starting Insulin Regimen
When insulin is initiated:
- Basal insulin analog is the preferred starting regimen 2
- Long-acting analogs (glargine U100/U300, degludec, detemir) are preferred over NPH insulin due to reduced hypoglycemia risk 2
- Ultra-long-acting analogs (glargine U300, degludec) have even less hypoglycemia than glargine U100 2
Common Pitfalls to Avoid
Never use insulin as a threat or describe it as a failure or punishment 1. The progressive nature of type 2 diabetes should be explained objectively and regularly to patients 1. Providers should emphasize that insulin is a normal and expected part of disease progression for many patients, not a personal failure.
Duration of Insulin Effect
Once insulin is initiated, its beneficial A1C effect is stable for 2 to 4 years in the majority of persons 2. This underscores that insulin is not just a temporary measure but often becomes a long-term component of therapy.
Real-World Evidence
Studies show that insulin therapy is estimated to be needed in up to 15% of type 2 diabetes cases 5, though the actual percentage requiring insulin at some point during their disease course is likely higher given the progressive nature of the condition. Research examining time to insulin initiation demonstrates that different second-line agents can delay but not eliminate the eventual need for insulin in many patients 6.